Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
N

Nightingale Health Oyj
OMXH:HEALTH

Watchlist Manager
Nightingale Health Oyj
OMXH:HEALTH
Watchlist
Price: 1.696 EUR 7.34% Market Closed
Market Cap: €102.3m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

HEALTH Price Targets Summary
Nightingale Health Oyj

Wall Street analysts forecast HEALTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HEALTH is 1.785 EUR with a low forecast of 1.01 EUR and a high forecast of 2.625 EUR.

HEALTH Lowest Forecast
Wall Street Target
1.01 EUR
-40% Downside
HEALTH Average Forecast
Wall Street Target
1.785 EUR
5% Upside
HEALTH Highest Forecast
Wall Street Target
2.625 EUR
55% Upside
Lowest
Price Target
1.01 EUR
40% Downside
Average
Price Target
1.785 EUR
5% Upside
Highest
Price Target
2.625 EUR
55% Upside
Nightingale Health Oyj Competitors:
Price Targets
GLPG
Galapagos NV
9% Upside
OGI
OrganiGram Holdings Inc
56% Upside
URBN
Urban Outfitters Inc
22% Upside
PHVS
Pharvaris NV
71% Upside
GLPG
Galapagos NV
9% Upside
OGI
OrganiGram Holdings Inc
56% Upside
URBN
Urban Outfitters Inc
22% Upside
PHVS
Pharvaris NV
71% Upside
SMMT
Summit Therapeutics Inc
117% Upside

Revenue
Forecast

15% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
15% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

For the last 7 years the compound annual growth rate for Nightingale Health Oyj's revenue is 15%. The projected CAGR for the next 3 years is 37%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

What are analyst estimates?

See Also

Summary
HEALTH intrinsic value, competitors valuation, and company profile.
DCF Valuation
HEALTH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HEALTH stock valuation using valuation multiples.
Wall Street Estimates
HEALTH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HEALTH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HEALTH's stock price target?
Price Target
1.785 EUR

According to Wall Street analysts, the average 1-year price target for HEALTH is 1.785 EUR with a low forecast of 1.01 EUR and a high forecast of 2.625 EUR.

What is Nightingale Health Oyj's Revenue forecast?
Projected CAGR
37%

For the last 7 years the compound annual growth rate for Nightingale Health Oyj's revenue is 15%. The projected CAGR for the next 3 years is 37%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.